Skip to main content

Azasetron









Azasetron


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search











































































Azasetron
Azasetron.png
Clinical data

AHFS/Drugs.com
International Drug Names
Routes of
administration
Oral
ATC code
  • none

Pharmacokinetic data
Bioavailability 90%
Excretion 60-70%
Identifiers
CAS Number
  • 123039-99-6

PubChem CID
  • 2264
IUPHAR/BPS
  • 2285
ChemSpider

  • 2177 ☑Y
UNII
  • 77HC7URR9Z
KEGG

  • D07481 ☑Y
ChEMBL
  • ChEMBL1598608
Chemical and physical data
Formula
C17H20ClN3O3
Molar mass 349.81 g/mol
3D model (JSmol)
  • Interactive image

.mw-parser-output .nobold{font-weight:normal}
  (verify)

Azasetron is an antiemetic which acts as a 5-HT3 receptor antagonist, pKi = 9.27 [1] It is used in the management of nausea and vomiting induced by cancer chemotherapy (such as cisplatin chemotherapy). Azasetron hydrochloride is given in a usual dose of 10 mg once daily by mouth or intravenously. It is approved for marketing in Japan, and marketed exclusively by Torii Pharmaceutical Co., Ltd. under the trade names "Serotone I.V. Injection 10 mg" and "Serotone Tablets 10 mg".[2] Pharmacokinetics data from S. Tsukagoshi.[3]



References[edit]





  1. ^ "Azasetron". drugcentral.org/. UNM School of Medicine. 2016-07-31. Retrieved 2016-11-11..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^ "Torii Pharmaceutical to Solely Market Antiemetic Drugs". Torii Pharmaceutical Co Ltd. 2009-01-13. Retrieved 2016-11-11.


  3. ^ Tsukagoshi, S. (1999-06-01). "[Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist]". Gan to Kagaku Ryoho. Cancer & Chemotherapy. 26 (7): 1001–1008. ISSN 0385-0684. PMID 10396331.














Retrieved from "https://en.wikipedia.org/w/index.php?title=Azasetron&oldid=814355925"





Navigation menu

























(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.664","walltime":"0.814","ppvisitednodes":{"value":4470,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":282865,"limit":2097152},"templateargumentsize":{"value":3829,"limit":2097152},"expansiondepth":{"value":14,"limit":40},"expensivefunctioncount":{"value":2,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":8011,"limit":5000000},"entityaccesscount":{"value":2,"limit":400},"timingprofile":["100.00% 577.443 1 -total"," 65.11% 375.963 1 Template:Drugbox"," 43.18% 249.333 1 Template:Infobox"," 21.43% 123.721 1 Template:Reflist"," 20.30% 117.203 17 Template:Navbox"," 13.66% 78.867 2 Template:Cite_web"," 13.30% 76.804 16 Template:Unbulleted_list"," 10.67% 61.595 1 Template:Serotonergics"," 5.28% 30.482 1 Template:Infobox_drug/chemical_formula"," 5.20% 30.032 1 Template:Cite_journal"]},"scribunto":{"limitreport-timeusage":{"value":"0.233","limit":"10.000"},"limitreport-memusage":{"value":4470980,"limit":52428800}},"cachereport":{"origin":"mw1333","timestamp":"20181215072913","ttl":1900800,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":92,"wgHostname":"mw1253"});});

Popular posts from this blog

Full-time equivalent

さくらももこ

13 indicted, 8 arrested in Calif. drug cartel investigation